MicroRNA 6843 (MIR6843)

MicroRNA 6843 (MIR6843), also known as hsa-mir-6843, is a human microRNA—a short (20–24 nucleotide) non-coding RNA molecule involved in the post-transcriptional regulation of gene expression[5]. MicroRNAs function by binding to target messenger RNAs (mRNAs), typically resulting in gene silencing via translational repression or mRNA degradation[3][5]. MIR6843 is annotated as a predicted microRNA and is catalogued in genomic databases, but its specific biological targets, tissue expression patterns, and physiological or pathological roles have not yet been well characterized in the scientific literature[4][5]. While microRNAs as a class are recognized for their involvement in developmental pathways, cell cycle regulation, and disease processes including cancer, there is currently no direct evidence or published data attributing a particular role to MIR6843 in these contexts. Chemically modified oligonucleotides known as antagomirs can in principle be designed to inhibit MIR6843, though these are generic tools for microRNA inhibition rather than approved drugs[6]. Therefore, while microRNA 6843 is a plausible target for molecular or therapeutic research, detailed information regarding its functions, disease associations, drug interactions, or safety concerns remains lacking.

Other names

hsa-mir-6843hsa-miR-6843microRNA mir-6843MIR6843

Antagomirs targeting microRNA 6843 inhibit its endogenous function by hybridizing to the mature miRNA, leading to loss of its regulatory activity[6]